News & Announcements

DEADLINE EXTENDED: CABRI Announces Undergraduate Fellowships and Scholarship Program

Press Release from 2022-08-18

ANN ARBOR, MI, AUGUST 18, 2022—The Cayman Biomedical Research Institute (CABRI) is pleased to announce that applications for our undergraduate fellowships and scholarship program are open.

Undergraduate fellowships are available on a competitive basis to undergraduate students who have been offered an unpaid research position by a qualified principal investigator. Up to $5,000 per semester is available to each mentee-mentor team, with the entire amount paid as compensation to the undergraduate. The principal investigator will be responsible for the mentorship and guidance of the student during the period of the award.

"These fellowships are an excellent training opportunity for undergraduates to expand their knowledge outside the lecture hall," said Kourtney Goode, Academic Relations Coordinator at Cayman Chemical. "Hands-on research is an equally valuable learning experience that introduces a student to a potential career path and fosters the growth of their talents."

Undergraduate fellowship applications may be submitted on the CABRI website from August 22nd to October 2nd, 2022, and awardees will be notified by October 16th, 2022. 

As part of CABRI's commitment to help college-bound students continue their education after losing a parent or guardian to sinonasal undifferentiated carcinoma (SNUC) or B-cell lymphoma, scholarships are available to support the continued education of these students.  

Scholarship applications are accepted throughout the year and are available on the CABRI website.

CABRI is a nonprofit foundation that helps reduce the impact of rare diseases by funding research and supporting expanded opportunities for emerging scientists and families affected by these diseases.

Contact CABRI with any questions about these funding opportunities. 


About Cayman Chemical
Cayman Chemical Company helps make research possible by supplying scientists worldwide with biochemical tools used to understand cancer, neurochemistry, oxidative injury, endocrinology, atherosclerosis, and other human health challenges. Our scientists are experts in the synthesis, purification, and characterization of biochemicals ranging from small drug-like heterocycles to complex biolipids, fatty acids, and many others for use as research reagents and qualified standards. We are also highly skilled in all aspects of assay and antibody development, protein expression, crystallization, and structure determination. In addition, Cayman Contract Services provides discovery and pre-clinical development services to the global pharmaceutical, biotechnology, and academic research markets. Our diverse suite of services leverages a team of over 150 highly skilled scientists with expertise in medicinal chemistry, structure-based drug design, complex multi-step organic synthesis, analytical chemistry, sample analysis, and custom assay development. Cayman performs generic drug development and production in both Ann Arbor, Michigan and Neratovice, Czech Republic.

About CABRI
Cayman Biomedical Research Institute (CABRI) is a nonprofit organization which supports research on the rare illnesses and orphan diseases that are often neglected by the corporate pharmaceutical industry and actively pursues new developments that will treat these diseases. To support this endeavor, we offer research grants to specific principal investigators at academic research institutions who have a plan to extend the clinical or pre-clinical development for these diseases as well as undergraduate grants to assist students to obtain experience in laboratories while performing research that aligns with CABRI’s mission. CABRI also provides scholarships to college-bound students who have lost a parent to SNUC (sinonasal undifferentiated carcinoma).